Cabozantinib,Nivolumab,Ipilimumab
BMS
['cabozantinib', 'nivolumab', 'ipilimumab', 'nivo', 'renal,(-adrenal)']
phase ii study of cabozantinib with nivolumab and ipilimumab in advanced #renalcellcarcinoma with variant histologies. presentation by . #asco23 written coverage by on urotoday &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology